1. Home
  2. IBN vs SYK Comparison

IBN vs SYK Comparison

Compare IBN & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IBN
  • SYK
  • Stock Information
  • Founded
  • IBN 1955
  • SYK 1941
  • Country
  • IBN India
  • SYK United States
  • Employees
  • IBN N/A
  • SYK N/A
  • Industry
  • IBN Commercial Banks
  • SYK Medical/Dental Instruments
  • Sector
  • IBN Finance
  • SYK Health Care
  • Exchange
  • IBN Nasdaq
  • SYK Nasdaq
  • Market Cap
  • IBN 121.2B
  • SYK 139.3B
  • IPO Year
  • IBN 1999
  • SYK N/A
  • Fundamental
  • Price
  • IBN $34.26
  • SYK $382.54
  • Analyst Decision
  • IBN
  • SYK Buy
  • Analyst Count
  • IBN 0
  • SYK 19
  • Target Price
  • IBN N/A
  • SYK $424.56
  • AVG Volume (30 Days)
  • IBN 5.4M
  • SYK 1.4M
  • Earning Date
  • IBN 04-22-2025
  • SYK 07-29-2025
  • Dividend Yield
  • IBN 0.70%
  • SYK 0.88%
  • EPS Growth
  • IBN 14.82
  • SYK N/A
  • EPS
  • IBN 0.83
  • SYK 7.40
  • Revenue
  • IBN $23,482,887,936.00
  • SYK $23,218,000,000.00
  • Revenue This Year
  • IBN N/A
  • SYK $10.70
  • Revenue Next Year
  • IBN $14.57
  • SYK $8.34
  • P/E Ratio
  • IBN $20.19
  • SYK $51.71
  • Revenue Growth
  • IBN 40.52
  • SYK 10.76
  • 52 Week Low
  • IBN $25.13
  • SYK $314.93
  • 52 Week High
  • IBN $34.50
  • SYK $406.19
  • Technical
  • Relative Strength Index (RSI)
  • IBN 56.67
  • SYK 53.71
  • Support Level
  • IBN $33.61
  • SYK $371.27
  • Resistance Level
  • IBN $34.50
  • SYK $385.40
  • Average True Range (ATR)
  • IBN 0.32
  • SYK 5.89
  • MACD
  • IBN -0.05
  • SYK -1.30
  • Stochastic Oscillator
  • IBN 61.48
  • SYK 47.65

About IBN ICICI Bank Limited

ICICI Bank Ltd provides banking services. The company's operating segments include Retail Banking; Wholesale Banking; Treasury, Life insurance, Other Banking Business, and Others. The company generates maximum revenue from the Retail Banking segment which includes exposures of the Bank, which satisfy the four qualifying criteria of a regulatory retail portfolio as stipulated by RBI guidelines on the Basel III framework as well as includes income from credit cards, debit cards, third party product distribution, and the associated costs. Geographical segments include Domestic operations and Foreign operations. The company generates the majority of its revenue from the domestic operations.

About SYK Stryker Corporation

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one fourth of Stryker's total revenue currently comes from outside the United States.

Share on Social Networks: